Access to MS treatments worldwide remains highly unequal. While research and innovation are making great strides, many people with multiple sclerosis are not benefiting from these advances. In this episode, Anne Helme, Head of Research and Access at the MS International Federation (MSIF), talks about the global challenges of treatment access, MSIF’s work to address them, and the hopes for a fairer future in MS care.

We cover:

• Why a global approach to access is more important than ever

• Where access to modern MS therapies is most limited

• The biggest barriers: cost, availability, regulations, and information gaps

• How MSIF and its members are working to improve access worldwide

• Options for patients in countries with limited or unaffordable treatments

• Developments that bring hope for the future

👉 Read the full blog article: Access to MS Treatments Worldwide – Interview with MSIF’s Anne Helme - https://ms-perspektive.com/132-anne-helme

👉 Learn more about MSIF’s work on access and advocacy: MSIF – Access to MS healthcare - https://www.msif.org/access-to-ms-healthcare/

---

A big thank you to Anne Helme and all her colleagues for everything they have reached already for the wordlwide MS community.

See you soon and try to make the best out of your life, Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.